The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
Ocean Bio-Chem Q2 EPS $0.27 Down From $0.36 YoY, Sales $15.69M Down From $15.70M YoY
Ocean Bio-Chem (NASDAQ:OBCI) reported quarterly earnings of $0.27 per share. This is a 25 percent decrease over earnings of $0.36 per share from the same period last year. The company reported $15.69 million in sales
Ocean Bio-Chem Subsidiary OdorStar Technology Highlights Kills Virus Causing COVID-19 ‘In Just 30 Seconds’
OdorStar Technology, LLC. a subsidiary of Ocean Bio-Chem, Inc. (NASDAQ:OBCI), announces it has received approval from The U.S. Environmental Protection Agency (EPA) for its PERFORMACIDE® brand of disinfectants